PineTree Therapeutics Inc Email Formats
Biotechnology Research • 
Cambridge, Massachusetts, United States • 21-50 Employees
PineTree Therapeutics Inc Email Formats
PineTree Therapeutics Inc uses 2 email formats. The most common is {first name}{last name} (e.g., johndoe@pinetreetx.com), used 93.8% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@pinetreetx.com | 93.8% |
{first name} | john@pinetreetx.com | 6.2% |
Key Contacts at PineTree Therapeutics Inc
Ho-Juhn Song
Ceo/Founder
John Jia
Director
Clemens Reinshagen
Executive Director Of Translational Research & Bd
Sung Hugh Choi
Sr. Director, Platform Biology And Strategic Alliances
David Savitsky
Director
Company overview
| Headquarters | 767 Concord Ave, Cambridge, Massachusetts 02138, US |
| Website | |
| Keywords | Oncology, Pancreatic Cancer, Breast Cancer, Nsclc, Bispecific Antibody, Solid Cancer |
| Founded | 2019 |
| Employees | 21-50 |
| Socials |
About PineTree Therapeutics Inc
Pinetree Therapeutics is an award-winning, pre-clinical stage biotechnology company based in Cambridge, Massachusetts. Dedicated to addressing unmet medical needs, such as drug resistance and tumor recurrence in targeted therapy, Pinetree Therapeutics is advancing the field with its novel AbReptorTM platform. While the primary focus is on oncology, Pinetree Therapeutics is expanding pipelines to other areas as well. The AbReptorTM platform enables the development of multi-specific antibodies designed to outperform conventional inhibitors and ADCs (Antibody Drug Conjugate) by degradation. Unlike traditional inhibitors, which are limited in their mechanism of action (blocking the signaling pathway), our antibodies demonstrate superior efficacy in targeting and degrading disease proteins. The platform's focus is on targeted degradation of membrane-bound and extracellular proteins, offering a distinct advantage over conventional inhibitors and intracellular degraders like PROTACs or GLUEs. Additionally, the unique mechanism of our platform has yielded promising preclinical results in ADC (/DAC/ARC) application, demonstrating its potential to significantly advance the field.
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
PineTree Therapeutics Inc has 12 employees across 6 departments.
Departments
Number of employees
Funding Data
Explore PineTree Therapeutics Inc's funding history, including investment rounds, total capital raised, and key backers.
PineTree Therapeutics Inc Tech Stack
Discover the technologies and tools that power PineTree Therapeutics Inc's digital infrastructure, from frameworks to analytics platforms.
Video players
Security
Security
Video players
UI frameworks
CDN
JavaScript libraries
CMS
JavaScript libraries
Programming languages
Analytics
Netherlands
Frequently asked questions
4.8
40,000 users
